Prothena | PRTA - EPS Earnings Per Share



Prothena reported $-2.34 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
-0.72 -2.34 Oct/30 2025
-2.34 -1.18 Aug/04 2025


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
ALKERMES USD 0.52 0.39 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Exelixis USD 0.75 0.13 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Prothena USD -2.34 1.26 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025